Thursday, February 23, 2012 11:02:33 AM
Threshold Pharmaceuticals-THLD
Threshold Pharmaceuticals, Inc. And Merck KGaA Announce Global Agreement To Co-Develop And Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
Friday, 3 Feb 2012 05:00am EST
Threshold Pharmaceuticals, Inc. Announces Positive Phase 2b Clinical Trial Results Of TH-302 In Patients With Pancreatic
Tuesday, 21 Feb 2012 05:15am EST
Share Structure:
Outstanding Shares
33,702,242 as of Oct 31, 2010
Authorized Shares
150,000,000 as of Sep 30, 2010
Preferred Shares Authorized
2,000,000 as of Sep 30, 2010
THLD - Daily Candlesticks
Threshold Pharmaceuticals, Inc. And Merck KGaA Announce Global Agreement To Co-Develop And Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
Friday, 3 Feb 2012 05:00am EST
Threshold Pharmaceuticals, Inc. Announces Positive Phase 2b Clinical Trial Results Of TH-302 In Patients With Pancreatic
Tuesday, 21 Feb 2012 05:15am EST
Share Structure:
Outstanding Shares
33,702,242 as of Oct 31, 2010
Authorized Shares
150,000,000 as of Sep 30, 2010
Preferred Shares Authorized
2,000,000 as of Sep 30, 2010
THLD - Daily Candlesticks
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
